Jonathan M. Woo

2.5k total citations · 1 hit paper
14 papers, 892 citations indexed

About

Jonathan M. Woo is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Jonathan M. Woo has authored 14 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Jonathan M. Woo's work include Drug Transport and Resistance Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and CAR-T cell therapy research (2 papers). Jonathan M. Woo is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and CAR-T cell therapy research (2 papers). Jonathan M. Woo collaborates with scholars based in United States, China and Canada. Jonathan M. Woo's co-authors include Alexander Marson, Theodore L. Roth, Eric Shifrut, Morgan E. Diolaiti, P. Jonathan Li, Julia Carnevale, Alan Ashworth, Victoria Tobin, Elaine J. Carlson and Y Ohta and has published in prestigious journals such as Cell, PLoS ONE and Science Advances.

In The Last Decade

Jonathan M. Woo

14 papers receiving 867 citations

Hit Papers

Genome-wide CRISPR Screens in Primary Human T Cells Revea... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan M. Woo United States 10 506 295 189 149 110 14 892
Jorge Luis Valdés González United States 13 273 0.5× 195 0.7× 392 2.1× 88 0.6× 48 0.4× 30 1.1k
Jessica Otte United States 17 449 0.9× 697 2.4× 71 0.4× 179 1.2× 61 0.6× 29 1.2k
Joel Gatlin United States 13 385 0.8× 171 0.6× 377 2.0× 321 2.2× 148 1.3× 26 1.1k
Magdalena Krupa United States 15 283 0.6× 132 0.4× 115 0.6× 139 0.9× 46 0.4× 19 652
Ashley I. Beyer United States 14 806 1.6× 86 0.3× 91 0.5× 210 1.4× 107 1.0× 17 1.1k
Patricia Jans Australia 15 601 1.2× 127 0.4× 220 1.2× 116 0.8× 54 0.5× 20 984
Guillermo S. Romano Ibarra United States 8 432 0.9× 222 0.8× 104 0.6× 163 1.1× 26 0.2× 10 702
Dan Zhou China 14 288 0.6× 293 1.0× 566 3.0× 40 0.3× 43 0.4× 30 1.0k
David J. Hughes United Kingdom 18 248 0.5× 276 0.9× 119 0.6× 83 0.6× 34 0.3× 37 900

Countries citing papers authored by Jonathan M. Woo

Since Specialization
Citations

This map shows the geographic impact of Jonathan M. Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Woo more than expected).

Fields of papers citing papers by Jonathan M. Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Woo. The network helps show where Jonathan M. Woo may publish in the future.

Co-authorship network of co-authors of Jonathan M. Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Woo. A scholar is included among the top collaborators of Jonathan M. Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Woo. Jonathan M. Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lee, Youjin, Derek Bogdanoff, Yutong Wang, et al.. (2021). XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment. Science Advances. 7(17). 83 indexed citations
2.
Simeonov, Dimitre R., Alexander Brandt, Alice Chan, et al.. (2019). A large CRISPR-induced bystander mutation causes immune dysregulation. Communications Biology. 2(1). 70–70. 16 indexed citations
3.
Shifrut, Eric, Julia Carnevale, Victoria Tobin, et al.. (2018). Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function. Cell. 175(7). 1958–1971.e15. 339 indexed citations breakdown →
4.
Hultquist, Judd F., Kathrin Schumann, Jonathan M. Woo, et al.. (2016). A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells. Cell Reports. 17(5). 1438–1452. 131 indexed citations
5.
Dahlin, Amber, Matthias Wittwer, Melanie de la Cruz, et al.. (2014). A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. Pharmacogenetics and Genomics. 25(2). 82–92. 23 indexed citations
6.
Zhan, Chau‐Jie, Sumei Chen, Cheng-Ta Ko, et al.. (2014). A novel 3D IC assembly process for ultra-thin chip stacking. 470–474. 3 indexed citations
7.
Ross, J Cosbie, Judith A. Badner, Helena Garrido, et al.. (2011). Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD. Human Genetics. 130(6). 795–805. 25 indexed citations
8.
DuBois, Steven G., Robert E. Goldsby, Mark R. Segal, et al.. (2011). Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: A report from the childhood cancer survivor study. Pediatric Blood & Cancer. 59(1). 52–56. 6 indexed citations
9.
Phuchareon, Janyaporn, Y Ohta, Jonathan M. Woo, David W. Eisele, & Osamu Tetsu. (2009). Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS ONE. 4(6). e6040–e6040. 88 indexed citations
10.
Greenhouse, Bryan, Alissa Myrick, Christian Dokomajilar, et al.. (2006). VALIDATION OF MICROSATELLITE MARKERS FOR USE IN GENOTYPING POLYCLONAL PLASMODIUM FALCIPARUM INFECTIONS. American Journal of Tropical Medicine and Hygiene. 75(5). 836–842. 87 indexed citations
11.
Putnam, Wendy S., Jonathan M. Woo, Yong Huang, & Leslie Z. Benet. (2005). Effect of the MDR1 C3435T Variant and P‐Glycoprotein Induction on Dicloxacillin Pharmacokinetics. The Journal of Clinical Pharmacology. 45(4). 411–421. 19 indexed citations
12.
Hamilton, Steven P., Jonathan M. Woo, Elaine J. Carlson, et al.. (2005). Analysis of four DLX homeobox genes in autistic probands. BMC Genetics. 6(1). 52–52. 60 indexed citations
13.
Putnam, Wendy S., et al.. (2003). The effect of induction conditions and MDR1 genotypes on dicloxacillin pharmacokinetics. Clinical Pharmacology & Therapeutics. 73(2). 7 indexed citations
14.
Murayama, Nobuo, et al.. (2003). The functional change of P‐glycoprotein on lymphocytes under induction conditions as a function of MDRL polymorphisms. Clinical Pharmacology & Therapeutics. 73(2). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026